Sagent Recalls Anti-Infection Drug Over Contamination

Law360, New York (May 18, 2010, 3:04 PM EDT) -- Sagent Pharmaceuticals Inc. has recalled intravenous anti-microbial metronidazole — which is used to treat infections — over contamination concerns following the discovery of two lots of the drug that were not properly sterile.

The nationwide recall covers all lots of metronidazole injection 500 mg/100 ml, which is manufactured by Claris Lifesciences Ltd. and distributed by Sagent in a single-dose plastic container. Specialty injectables company Sagent said the recalled product was distributed to hospitals, wholesalers and other distributors around the U.S. from February to May.

If an...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.